The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
10-year follow-up results of perioperative chemotherapy with doxorubicin (DXR) and ifosfamide (IFM) for high-grade soft tissue sarcomas (STS) in the extremities: Japan Clinical Oncology Group study JCOG0304.
 
Kazuhiro Tanaka
Honoraria - Eisai; Novartis; Taiho Pharmaceutical
 
Junki Mizusawa
No Relationships to Disclose
 
Norifumi Naka
No Relationships to Disclose
 
Akira Kawai
Honoraria - Eisai; Lilly; Novartis; Taiho Pharmaceutical; Takara Bio
 
Hirohisa Katagiri
Honoraria - Daiichi Sankyo; MSD; SHIONOGI
 
Toru Hiruma
No Relationships to Disclose
 
Yoshihiro Matsumoto
Honoraria - Eisai
 
Hiroyuki Tsuchiya
No Relationships to Disclose
 
Robert Nakayama
No Relationships to Disclose
 
Hiroshi Hatano
No Relationships to Disclose
 
Makoto Emori
No Relationships to Disclose
 
Masami Hosaka
No Relationships to Disclose
 
Yukihiro Yoshida
No Relationships to Disclose
 
Takeshi Okamoto
No Relationships to Disclose
 
Satoshi Abe
No Relationships to Disclose
 
Kunihiro Asanuma
No Relationships to Disclose
 
Ryohei Yokoyama
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Toshifumi Ozaki
No Relationships to Disclose
 
Yukihide Iwamoto
No Relationships to Disclose